AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Psyence Biomedical Ltd.

$5.4 +$0.40 (+8.00%)
NASDAQ · 11 Sep 2026 20:00 UTC
Previous Close
$4.97
Day Range
$4.93$5.63
Year Range
$1.92$216.41
Market Cap
102.7K
AVG Volume
88.95K
Trailing/Forward PE
0/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
NASDAQUS
Net Income (USD) · TTM
-30M-20M-10M010M20M21 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
PBM Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
23 Q3-25.73M
23 Q21.29M
23 Q12.93M
22 Q45.04M
22 Q38.01M
22 Q214.07M
22 Q113.26M
21 Q411.18M
21 Q38.22M
Operating Income (USD) · TTM
-3M-2M-1M021 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
PBM Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
23 Q3-2.53M
23 Q2-2.41M
23 Q1-2.48M
22 Q4-2.09M
22 Q3-1.37M
22 Q2-1.12M
22 Q1-919.78K
21 Q4-334.29K
21 Q3-15.97K
EBITDA (USD) · TTM
-5M05M10M15M20M21 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
PBM EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
23 Q3-1.63M
23 Q22.03M
23 Q13.96M
22 Q46.67M
22 Q310.4M
22 Q217.96M
22 Q116.87M
21 Q414.2M
21 Q310.5M
Cash Flows (USD) · TTM
-1.5M-1M-500K022 Q122 Q222 Q322 Q423 Q123 Q223 Q3
PBM Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
23 Q3-1.05M
23 Q2-1.14M
23 Q1-979.84K
22 Q4-853.45K
22 Q3-519.6K
22 Q2-1.25M
22 Q1-1.17M
EPS (USD) · TTM
-2-10121 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
PBM EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
23 Q3-1.94
23 Q2-0.03
23 Q10.09
22 Q40.17
22 Q30.27
22 Q20.45
22 Q10.42
21 Q4-0.27
21 Q3-0.53
Expenses (USD) · TTM
01M2M3M4MR&DSG&ACapex21 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
PBM Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
23 Q32.1M
23 Q23.21M
23 Q13.27M
22 Q43.05M
22 Q32.6M
22 Q21.12M
22 Q1919.77K
21 Q4660.9K
21 Q3342.57K
Shares Outstanding (USD) · TTM
-100M0100M200M300MBuybacks (Repurchases)Stock-Based Compensation22 Q122 Q222 Q322 Q423 Q123 Q223 Q3
PBM Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
23 Q3247.42M
23 Q2247.42M
23 Q1243.11M
22 Q4243.11M
22 Q30
22 Q20
22 Q10
Employee Count
051015202420252026
PBM Employee Count by quarter
PeriodEmployee Count
202612
202512
202410
PE Ratio
0200004000060000med 20603.31Jan 24Feb 24Feb 24Feb 24Feb 24
PBM PE Ratio by quarter
PeriodPE Ratio
Feb 2413860.23
Feb 2417004.55
Feb 2420603.31
Feb 2436798.41
Jan 2459553.32
Free Cash Flow Yield
-0.08%-0.06%-0.04%-0.02%0%med -0%Feb 24Apr 24Jun 24Aug 24Sep 24Nov 24Jan 25
PBM Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Jan 25-0.07%
Jan 25-0.08%
Jan 25-0.06%
Dec 24-0.06%
Dec 24-0.04%
Dec 24-0.07%
Dec 24-0.06%
Nov 24-0.04%
Nov 24-0.04%
Nov 24-0.04%
Nov 24-0.02%
Nov 24-0.03%
Oct 24-0.02%
Oct 24-0.02%
Oct 24-0.02%
Oct 24-0.02%
Sep 24-0.02%
Sep 24-0.02%
Sep 24-0.01%
Sep 24-0.01%
Aug 24-0%
Aug 24-0%
Aug 24-0%
Aug 24-0%
Aug 24-0%
Jul 24-0%
Jul 24-0%
Jul 24-0.01%
Jul 24-0.01%
Jun 24-0.01%
Jun 24-0%
Jun 24-0%
Jun 24-0%
May 24-0%
May 24-0%
May 24-0%
May 24-0%
May 24-0%
Apr 24-0%
Apr 24-0%
Apr 24-0%
Apr 24-0%
Mar 24-0%
Mar 24-0%
Mar 24-0%
Mar 24-0%
Mar 24-0%
Feb 24-0.01%
Feb 24-0.01%
Feb 24-0%
Feb 24-0%
Jan 24-0%
EV/EBITDA
010000200003000040000med 13050.55Jan 24Feb 24Feb 24Feb 24Feb 24
PBM EV/EBITDA by quarter
PeriodEV/EBITDA
Feb 248779.59
Feb 2410771.15
Feb 2413050.55
Feb 2423308.26
Jan 2437720.84
Price to Book
00.511.5med 0.5Nov 25Jan 26Feb 26Apr 26Jun 26Jul 26Sep 26
PBM Price to Book by quarter
PeriodPrice to Book
Sep 260.67
Sep 260.57
Aug 260.53
Aug 260.54
Aug 260.43
Aug 260.43
Jul 260.4
Jul 260.37
Jul 260.38
Jul 260.37
Jul 260.38
Jun 260.37
Jun 260.39
Jun 260.42
Jun 260.44
May 260.52
May 260.51
May 260.61
May 260.7
May 260.78
Apr 260.99
Apr 260.95
Apr 260.33
Apr 260.31
Mar 260.32
Mar 260.3
Mar 260.31
Mar 260.31
Feb 260.32
Feb 260.31
Feb 260.39
Feb 260.39
Jan 260.5
Jan 260.57
Jan 260.52
Jan 260.63
Jan 260.62
Dec 250.73
Dec 250.75
Dec 251.18
Dec 251.32
Nov 251.15
Nov 251.12
Psyence Biomedical Ltd.
PBM
Stockpicker

Video analysis: PBM

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: PBM

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.